Doximity downgraded at J.P. Morgan on valuation and advertising concerns
Source: SeekingAlpha
2025-10-10 11:08:59 ET
More on Doximity
- Doximity: Valuation Is Too Expensive For My Liking
- Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript
- Doximity: Slowing Sales And EBITDA Growth
- Doximity, LivaNova downgraded as Goldman Sachs reviews MedTech and Health IT coverage
- Doximity rises on Q1 beat; buys Canadian AI-based clinical reference firm
Read the full article on Seeking Alpha
For further details see:
Doximity downgraded at J.P. Morgan on valuation and advertising concerns
Doximity Inc. Class A
NASDAQ: DOCS
DOCS Trading
-2.4% G/L:
$24.39 Last:
746,042 Volume:
$24.96 Open:
DOCS Latest News
February 23, 2026 01:35:00 am
Got $50,000? This Unbelievable SaaS Compounder Is Hiding in Plain Sight.
DOCS Stock Data
$5,029,624,926
180,645,361
N/A
184
N/A
Healthcare Providers & Services
Healthcare
US
San Francisco
